Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 1/20 | 0.54 |
| ▸ | CTSK | P43235 | 1/20 | 0.54 |
| ▸ | MAOA | P21397 | 1/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.53 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.52 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL705394 | 0.98 | CTSS (0.56) | CTSSCTSKMAOAMAOBOPRM1 | |
| SCHEMBL7756938 | 0.93 | OPRM1 (0.58) | CTSSCTSKMAOAMAOBOPRM1 | |
| SCHEMBL1609623 | 0.89 | MAOA (0.58) | CTSSCTSKMAOAMAOBSLC18A2 | |
| SCHEMBL3172080 | 0.88 | MAOA (0.47) | CTSSCTSKMAOAMAOBSLC18A2 | |
| SCHEMBL3158459 | 0.88 | RAB9A (0.49) | CTSSCTSKSIGMAR1 | |
| SCHEMBL2440428 | 0.88 | SLC18A3 (0.60) | MAOAMAOBSIGMAR1OPRM1OPRD1 | |
| SCHEMBL7419921 | 0.88 | SLC18A3 (0.60) | MAOAMAOBSIGMAR1OPRM1OPRD1 | |
| SCHEMBL9133642 | 0.88 | SLC18A3 (0.60) | MAOAMAOBSIGMAR1OPRM1OPRD1 | |
| SCHEMBL4670600 | 0.88 | OPRM1 (0.50) | CTSSCTSKOPRM1OPRD1OPRK1 | |
| SCHEMBL6049169 | 0.86 | SIGMAR1 (0.61) | SIGMAR1OPRM1OPRD1OPRK1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1612 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540284-B2 | Methods for processing liquid organic hydrogen carriers | SAUDI ARABIAN OIL COMPANY (SA) | 2026-02-03 | — | — | US | claimed |
| WO-2025128463-A1 | METHODS FOR PROCESSING LIQUID ORGANIC HYDROGEN CARRIERS | SAUDI ARABIAN OIL COMPANY (SA) | 2025-06-19 | — | — | WO | claimed |
| US-20250188004-A1 | INTEGRATED NAPHTHA REFORMING AND BENZYL TOLUENE PRODUCTION PROCESS | SAUDI ARABIAN OIL COMPANY (SA) | 2025-06-12 | — | — | US | claimed |
| US-20250188370-A1 | METHODS FOR PROCESSING LIQUID ORGANIC HYDROGEN CARRIERS | SAUDI ARABIAN OIL COMPANY (SA) | 2025-06-12 | — | — | US | claimed |
| WO-2025111255-A1 | METHODS FOR PROCESSING LIQUID ORGANIC HYDROGEN CARRIERS | SAUDI ARABIAN OIL COMPANY (SA) | 2025-05-30 | — | — | WO | claimed |
| US-20250163335-A1 | METHODS FOR PROCESSING LIQUID ORGANIC HYDROGEN CARRIERS | SAUDI ARABIAN OIL COMPANY (SA) | 2025-05-22 | — | — | US | claimed |
| US-12281064-B2 | Methods for dehydrogenation of perhydro-benzyltoluene | CHEVRON U.S.A. INC. (US) | 2025-04-22 | — | — | US | claimed |
| US-20250066271-A1 | METHODS FOR DEHYDROGENATION OF PERHYDRO-BENZYLTOLUENE | CHEVRON U.S.A. INC. | 2025-02-27 | — | — | US | claimed |
| CN-118616040-A | Preparation method and application of organic liquid dehydrogenation catalyst based on solution modification | 中氢源安(上海)氢能科技有限公司 | 2024-09-10 | — | — | CN | claimed |
| CN-115869969-B | Dehydrogenation catalyst, preparation method thereof and dehydrogenation method | 中安浩源(上海)氢能科技有限公司 | 2024-09-06 | — | — | CN | claimed |
| US-5679282-A | Chiral 2,6-difluorobenzene derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1997-10-21 | — | — | US | claimed |
| EP-0655062-B1 | MORPHOLINO/THIOMORPHOLINO-TERMINATED ALKYLAMINO ETHYNYL ALANINE AMINO DIOL COMPOUNDS AS RENIN INHIBITORS | SEARLE & CO (US) | 1997-10-08 | — | — | EP | claimed |
| EP-0763015-A1 | SYSTEMATIC MODULAR PRODUCTION OF AMINIMIDE- AND OXAZOLONE- BASED MOLECULES HAVING AT LEAST TWO STRUCTURAL DIVERSITY ELEMENTS | ARQULE, INC. (US) | 1997-03-19 | — | — | EP | claimed |
| WO-1995032184-A1 | SYSTEMATIC MODULAR PRODUCTION OF AMINIMIDE- AND OXAZOLONE- BASED MOLECULES HAVING AT LEAST TWO STRUCTURAL DIVERSITY ELEMENTS | ARQULE, INC. (US) | 1995-11-30 | — | — | WO | claimed |
| EP-0408995-B1 | Liquid crystal medium with limited temperature-dependence of the d/p coefficient | MERCK PATENT GMBH (DE) | 1995-11-08 | — | — | EP | claimed |
| US-5139698-A | Achiral liquid crystal compound with doping component | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1992-08-18 | — | — | US | claimed |
| EP-0444448-A2 | Phenylcyclohexylethane and liquid crystal medium | MERCK PATENT GmbH (DE) | 1991-09-04 | — | — | EP | claimed |
| US-5043093-A | Liquid crystals | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1991-08-27 | — | — | US | claimed |
| EP-0408995-A2 | Liquid crystal medium with limited temperature-dependence of the d/p coefficient | MERCK PATENT GmbH (DE) | 1991-01-23 | — | — | EP | claimed |
| US-4702562-A | MIXTURE-FOR MULTIPLEXING | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1987-10-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540284-B2 | Methods for processing liquid organic hydrogen carriers | HOGA1, HAO2, HVCN1 | CTSS 2956/4885CTSK 3190/4885MAOA 1033/4885 |
| US-20250188004-A1 | INTEGRATED NAPHTHA REFORMING AND BENZYL TOLUENE PRODUCTION PROCESS | FLI1, LIPA, TCF4 | CTSS 947/4885CTSK 2137/4885MAOA 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.